scholarly journals Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma

2017 ◽  
Vol 35 (3) ◽  
pp. 289-294 ◽  
Author(s):  
Gwi Eon Kim ◽  
Hee-Sung Song ◽  
Ki Jung Ahn ◽  
Young Suk Kim
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiation Therapy ◽  
Radiation Recall ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

Recurrent radiation recall dermatitis 40 years after radiation therapy for breast cancer

2021 ◽  
Author(s):  
Muhammad F. Jamaluddin ◽  
Aswin G. Abraham ◽  
Geetha Menon ◽  
Thomas Nakatsui ◽  
Wilson Roa
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Radiation Recall ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

Efflorescence of scalp cysts during vemurafenib treatment following brain radiation therapy: a radiation recall dermatitis?

2013 ◽  
Vol 23 (4) ◽  
pp. 544-545 ◽  
Author(s):  
Marie Reigneau ◽  
Florence Granel-Brocard ◽  
Lionnel Geoffrois ◽  
Anne-Sophie Bauman ◽  
Philippe Tréchot ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Radiation Recall ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis ◽  
Brain Radiation

scholarly journals Idiopathic Radiation Recall Dermatitis Developing Nine Months after Cessation of Cisplatin Therapy in Treatment of Squamous Cell Carcinoma of the Tonsil

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Stephen M. Melnyk ◽  
Kenneth F. More ◽  
Edward F. Miles
Keyword(s):  
Squamous Cell Carcinoma ◽  
Radiation Therapy ◽  
Radiation Dose ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Combined Therapy ◽  
Suspected Case ◽  
Radiation Recall ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

To report on a suspected case of idiopathic radiation recall dermatitis in an individual nine months after radiation and chemotherapy treatment of squamous cell carcinoma of the right tonsil. Radiation recall dermatitis is the development of a reaction in a previously irradiated area of skin after the administration of an aggravating medication. A review of the literature revealed several cases of radiation recall dermatitis that occur following radiation therapy and the institution of chemotherapy. Other medications have also been implicated in radiation recall dermatitis; however, this patient has not started any new medications since completion of his combined therapy. The patient developed this skin reaction in a distribution pattern identical to the area that received the highest radiation dose suggesting a possible link between radiation recall dermatitis and radiation dose. Radiation recall dermatitis is a reaction that is typically seen shortly after the reinstitution of chemotherapy during radiation therapy. This case illustrates that other medical etiologies are possible and suggests a relationship between radiation recall dermatitis and the total radiation dose an area receives.

Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy

2003 ◽  
Vol 91 (2) ◽  
pp. 421-422 ◽  
Author(s):  
Benjamin M Schwartz ◽  
Deepak Khuntia ◽  
Alexander W Kennedy ◽  
Maurie Markman
Keyword(s):  
Radiation Therapy ◽  
Radiation Recall ◽  
Pelvic Radiation ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

scholarly journals Capecitabine-induced radiation recall phenomenon: a case report

F1000Research ◽  
2012 ◽  
Vol 1 ◽  
pp. 64 ◽  
Author(s):  
José Aguilar ◽  
Elena García ◽  
Elisa García-Garre
Keyword(s):  
Radiation Therapy ◽  
Inflammatory Reaction ◽  
Radiation Therapy Oncology Group ◽  
Skin Toxicity ◽  
Local Relapse ◽  
Radiation Recall ◽  
First Case ◽  
Long Time ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

Radiation recall dermatitis is defined as an inflammatory reaction of the skin at the site of previous irradiation. Different drugs have been associated with triggering this phenomenon, and it can also affect other areas and organs where previous radiotherapy has been administered. The time gap between the inflammatory reaction and previous radiation can range from days to several years.We report what we believe to be the first case of Capecitabine-induced Radiation Therapy Oncology Group (RTOG) Grade 4 recall skin toxicity (ulcerating dermatitis), which occurred three years after skin irradiation. Clinicians should be aware of this phenomenon, even when considering patients for whom it has been a long time since previous radiation therapy. This unusual and late drug side effect should be borne in mind in the differential diagnosis and management of advanced-disease patients as it may be confused with local relapse or infectious complication of previously operated areas.

Radiation Recall Dermatitis after Bortezomib Therapy.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 5103-5103
Author(s):  
Alpesh J. Amin ◽  
Michael Maroules
Keyword(s):  
Multiple Myeloma ◽  
Radiation Therapy ◽  
Skin Reaction ◽  
Causative Agent ◽  
Drug Hypersensitivity ◽  
Similar Reaction ◽  
Radiation Recall ◽  
Inflammatory Skin ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

Abstract Introduction: Radiation recall dermatitis (RRD) is an inflammatory skin reaction at a site of previous radiation therapy after the administration of a medication, usually a chemotherapeutic agent. A radiation recall reaction has not been previously reported with bortezomib. Case Report: A seventy-year-old man with stage III IgD multiple myeloma was treated with bortezomib after previous treatments with pulse decadron and cyclophosphamide. The patient was treated ten years earlier for a chest wall sarcoma with a local resection and radiation therapy to the tumor bed. After receiving bortezomib therapy for multiple myeloma, the patient developed erythema, desquamation, and ulceration only at the site of radiation therapy ten years prior. The patient received a dose reduced second infusion, causing a similar reaction. Discussion: RRD is an inflammatory skin reaction that develops in a previously irradiated area after administration of certain promoting agents, most often with chemotherapy. Unlike radiation enhancement, there may be a long interval between the eruption and the administration of the causative agent. A number of drugs have been associated with this phenomenon, particularly the anthracyclines. Bortezomib has not been previously described as a causative agent for RRD. Erythema is the most common sign, which may be painful. Vesiculation, desquamation, and ulceration have also been reported. Histologically, the involved areas reveal epidermal dysplasia, necrotic keratinocytes, mixed inflammatory reaction, and sometimes psoriasiform dermatitis. Dose reduction, and the use of corticosteroids have been used to prevent recurrence of RRD, although rechallenge with the same agent may not lead to RRD again. The pathogenesis of this local phenomenon is not well understood, although an idiosyncratic drug hypersensitivity reaction has been proposed.

scholarly journals Case Report: Capecitabine-induced radiation recall phenomenon: a case report

F1000Research ◽  
2013 ◽  
Vol 1 ◽  
pp. 64 ◽  
Author(s):  
José Aguilar ◽  
Elena García ◽  
Elisa García-Garre
Keyword(s):  
Radiation Therapy ◽  
Case Report ◽  
Inflammatory Reaction ◽  
Radiation Therapy Oncology Group ◽  
Skin Toxicity ◽  
Local Relapse ◽  
Radiation Recall ◽  
Long Time ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

Radiation recall dermatitis is defined as an inflammatory reaction of the skin at the site of previous irradiation. Different drugs have been associated with triggering this phenomenon, and it can also affect other areas and organs where previous radiotherapy has been administered. The time gap between the inflammatory reaction and previous radiation can range from days to several years. We report a case of capecitabine-induced Radiation Therapy Oncology Group (RTOG) grade 4 (ulcerating dermatitis) recall skin toxicity of skin irradiated 3 years previously. To our knowledge, this is the first reported case of capecitabine-induced RTOG grade 4 (ulcerating dermatitis) recall skin toxicity of previously irradiated skin. Clinicians should be aware of this phenomenon, even when considering patients for whom it has been a long time since previous radiation therapy. This unusual and late drug side effect should be borne in mind in the differential diagnosis and management of advanced-disease patients as it may be confused with local relapse or infectious complication of previously operated areas.

scholarly journals Radiation recall dermatitis following letrozole administration in patient with a remote history of radiation therapy

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Evan Sweren ◽  
Pathik Aravind ◽  
Robert Dembinski ◽  
Catherine Klein ◽  
Mehran Habibi ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Patient Specific ◽  
Long Term Outcomes ◽  
Radiation Recall ◽  
Health Concerns ◽  
History Of ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

AbstractWe report the case of letrozole-induced radiation recall dermatitis (RRD) in a patient with a remote history of radiation therapy. There is only one previously known case of RRD triggered by letrozole in a patient with a recent (<3 month) history of radiation. Previously, only four other cases of aromatase-inhibitor-induced RRD have been reported. This case is significant for cancer care teams considering personalized treatments. In addition, improved long-term outcomes in cancer patients may lead to increases in and underdiagnoses of RRD. Likewise, RRD is patient specific, exacerbating health concerns, and can be difficult to recognize without proper awareness, documentation, and classification of triggering drugs. The authors hope to address these issues in this report.

A case of potential radiation recall dermatitis induced by chemotherapy, following low-dose total-skin electron beam therapy

2019 ◽  
Vol 29 (6) ◽  
pp. 671-672 ◽  
Author(s):  
Carl Lamoureux ◽  
Emilie Gerard ◽  
Nora Ouhabrache ◽  
Feyrouz Toukal ◽  
Anne Pham-Ledard ◽  
...  
Keyword(s):  
Electron Beam ◽  
Low Dose ◽  
Radiation Recall ◽  
Electron Beam Therapy ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis
Sign in / Sign up

Export Citation Format

Share Document